ideaForge Bumper Listing, Investors Nearly Doubled Their Investments
Drone maker ideaForge debuted at a 94% premium at Rs 1,305 per share on the exchanges on Friday after the listing was moved up to...
Category : MARKETS
JP Morgan Chase Bank Pays Rs 22.1 Lakh to SEBI over FPI Regulations Violations
JP Morgan Chase Bank (JPMC) settled with the Securities and Exchange Board of India (SEBI) for Rs 22.1 lakh in a case of alleged violations...
Hindustan Zinc to Give Interim Dividend of Rs 7; How Much Will Vedanta Get?
Hindustan Zinc announced an interim dividend of Rs 7 on July 8, amounting to a total outgo of Rs 2,957.72 crore. The first interim dividend...
HDFC Bank to Replace HDFC Ltd on Global Indices
As per an MSCI notice released on Friday, Housing Development Finance Corporation (HDFC) Ltd will be replaced by HDFC Bank on July 13, following the...
More Than 60 Small-Cap Stocks Surge Up To 41% in Market’s Exceptional Rally
The Indian market witnessed another remarkable week, characterised by record-breaking milestones. The positive momentum was driven by consistent buying from foreign institutional investors (FIIs), the...
Reliance Retail Approves Share Capital Reduction; Faces Investors Backlash and Anger
Reliance Retail, on Friday, announced the reduction of its equity share capital to the extent held by shareholders other than its promoters and holding company....
Multiple Stocks Rose 15-27% in 2 Months: Non-Listed Stocks Ushered in Bull Rally
Several unlisted stocks traded offline through select brokers have surged between 15% and 27% in the past two months amid the positive outlook for the...
Sebi Circular Raises MF Trustees Accountability
The Securities and Exchange Board of India (Sebi) on Friday issued a detailed circular placing the onus of protecting mutual fund (MF) trustees on the...
Cyient DLM Trades at 45% Premium in Grey Market
Analysts said that electronic manufacturing services Cyient DLM seems to be in great demand in the grey market as its shares traded with a 45%...
Aurobindo Pharma Arm to Market Biosimilar to Treat Crohn’s Disease, Arthritis
Aurobindo Pharma has proclaimed that its wholly owned subsidiary CuraTeQ Biologics has got into a special licence deal with the US-based BioFactura for biosimilar product...